Attenuating Aβ production, for instance by inhibiting either of the respective proteases BACE-1 or γ-secretase, is considered an attractive strategy for preventing disease progression in patients suffering from Alzheimer's Disease. The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.